Physician profile
John W Waterfallen
NPI 1164417309
$2,817.44
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $904 · 2020: $616 · 2021: $737 · 2022: $518 · 2023: $42.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $42.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $42.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $664.70 | 2019-2023 | Lo Loestrin Fe |
| Lupin INC. | $421.39 | 2019-2021 | |
| Amgen INC. | $381.76 | 2019-2021 | |
| Pfizer INC. | $346.05 | 2019-2022 | |
| Aspira Women'S Health INC | $256.26 | 2021-2022 | |
| Daiichi Sankyo INC. | $133.99 | 2020-2021 | |
| Therapeuticsmd, INC. | $123.20 | 2019-2022 | |
| Eisai INC. | $92.79 | 2020-2021 | |
| Hologic Sales and Service, LLC | $68.08 | 2019-2021 | |
| Scynexis, INC. | $55.75 | 2022 | |
| Novo Nordisk INC | $42.94 | 2019-2020 | |
| Urovant Sciences INC | $36.81 | 2021-2022 | |
| Avion Pharmaceuticals | $27.13 | 2019-2020 | |
| Bausch Health US, LLC | $26.99 | 2022 | |
| Seqirus USA INC | $19.07 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $15.33 | 2023 | Seglentis |
| Amag Pharmaceuticals, INC. | $14.75 | 2019 | |
| Exeltis, USA INC. | $14.47 | 2022 | |
| Allergan, INC. | $14.04 | 2019 | |
| Currax Pharmaceuticals LLC | $13.33 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.23 | 2019 | |
| Sage Therapeutics, LLC | $12.55 | 2022 | |
| Mayne Pharma Commercial LLC | $11.82 | 2022 | |
| Merck Sharp & Dohme LLC | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Waterfallen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.